A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants
Condition(s):Osteoporosis, PostmenopausalLast Updated:July 16, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Osteoporosis, PostmenopausalLast Updated:July 16, 2018Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:March 9, 2023Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:February 3, 2022Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:May 17, 2018Completed
Condition(s):Post-Menopausal OsteoporosisLast Updated:June 17, 2011Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:April 29, 2009Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:March 11, 2008Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:March 15, 2021Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:February 3, 2022Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:February 3, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.